Good morning and thank you for joining Bentley Systems Q4 and Full Year 2025 Results and 2026 financial outlook. I'm Eric Boyer, Bentley Systems Investor Relations Officer. On the webcast today, we ...
Background Patients with heart failure (HF) frequently suffer from undetected declines in cardiorespiratory fitness (CRF), which significantly increases their risk of poor outcomes. However, current ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results